TY - JOUR AU - Agaram, N. P. AU - Zhang, L. AU - Sung, Y. S. PY - 2016 DA - 2016// TI - Recurrent NTRK1 gene fusions define a novel subset of locally aggressive lipofibromatosis-like neural tumors JO - Am J Surg Pathol VL - 40 UR - https://doi.org/10.1097/PAS.0000000000000675 DO - 10.1097/PAS.0000000000000675 ID - Agaram2016 ER - TY - JOUR AU - Amatu, A. AU - Sartore-Bianchi, A. AU - Siena, S. PY - 2016 DA - 2016// TI - NTRK gene fusions as novel targets of cancer therapy across multiple tumour types JO - ESMO Open VL - 1 UR - https://doi.org/10.1136/esmoopen-2015-000023 DO - 10.1136/esmoopen-2015-000023 ID - Amatu2016 ER - TY - JOUR AU - Coulier, F. AU - Martin-Zanca, D. AU - Ernst, M. PY - 1989 DA - 1989// TI - Mechanism of activation of the human trk oncogene JO - Mol Cell Biol VL - 9 UR - https://doi.org/10.1128/MCB.9.1.15 DO - 10.1128/MCB.9.1.15 ID - Coulier1989 ER - TY - JOUR AU - Schram, A. M. AU - Chang, M. T. AU - Jonsson, P. PY - 2017 DA - 2017// TI - Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance JO - Nat Rev Clin Oncol VL - 14 UR - https://doi.org/10.1038/nrclinonc.2017.127 DO - 10.1038/nrclinonc.2017.127 ID - Schram2017 ER - TY - JOUR AU - Cocco, E. AU - Scaltriti, M. AU - Drilon, A. PY - 2018 DA - 2018// TI - NTRK fusion-positive cancers and TRK inhibitor therapy JO - Nat Rev Clin Oncol VL - 15 UR - https://doi.org/10.1038/s41571-018-0113-0 DO - 10.1038/s41571-018-0113-0 ID - Cocco2018 ER - TY - JOUR AU - Tognon, C. AU - Knezevich, S. R. AU - Huntsman, D. PY - 2002 DA - 2002// TI - Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma JO - Cancer Cell VL - 2 UR - https://doi.org/10.1016/S1535-6108(02)00180-0 DO - 10.1016/S1535-6108(02)00180-0 ID - Tognon2002 ER - TY - JOUR AU - Drilon, A. AU - Li, G. AU - Dogan, S. PY - 2016 DA - 2016// TI - What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC) JO - Ann Oncol VL - 27 UR - https://doi.org/10.1093/annonc/mdw042 DO - 10.1093/annonc/mdw042 ID - Drilon2016 ER - TY - JOUR AU - Davis, J. L. AU - Lockwood, C. M. AU - Albert, C. M. PY - 2018 DA - 2018// TI - Infantile NTRK-associated mesenchymal tumors JO - Pediatr Dev Pathol VL - 21 UR - https://doi.org/10.1177/1093526617712639 DO - 10.1177/1093526617712639 ID - Davis2018 ER - TY - JOUR AU - Halalsheh, H. AU - McCarville, M. B. AU - Neel, M. PY - 2018 DA - 2018// TI - Dramatic bone remodeling following larotrectinib administration for bone metastasis in a patient with TRK fusion congenital mesoblastic nephroma JO - Pediatr Blood Cancer VL - 65 UR - https://doi.org/10.1002/pbc.27271 DO - 10.1002/pbc.27271 ID - Halalsheh2018 ER - TY - JOUR AU - Pavlick, D. AU - Schrock, A. B. AU - Malicki, D. PY - 2017 DA - 2017// TI - Identification of NTRK fusions in pediatric mesenchymal tumors JO - Pediatr Blood Cancer VL - 64 UR - https://doi.org/10.1002/pbc.26433 DO - 10.1002/pbc.26433 ID - Pavlick2017 ER - TY - JOUR AU - Laetsch, T. W. AU - DuBois, S. G. AU - Mascarenhas, L. PY - 2018 DA - 2018// TI - Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study JO - Lancet Oncol VL - 19 UR - https://doi.org/10.1016/S1470-2045(18)30119-0 DO - 10.1016/S1470-2045(18)30119-0 ID - Laetsch2018 ER - TY - JOUR AU - Drilon, A. AU - Laetsch, T. W. AU - Kummar, S. PY - 2018 DA - 2018// TI - Efficacy of larotrectinib in TRK fusion-positive cancers in adults and Children JO - N Engl J Med VL - 378 UR - https://doi.org/10.1056/NEJMoa1714448 DO - 10.1056/NEJMoa1714448 ID - Drilon2018 ER - TY - JOUR AU - Ardini, E. AU - Menichincheri, M. AU - Banfi, P. PY - 2016 DA - 2016// TI - Entrectinib, a Pan-TRK, ROS1, and ALK inhibitor with activity in multiple molecularly defined cancer indications JO - Mol Cancer Ther VL - 15 UR - https://doi.org/10.1158/1535-7163.MCT-15-0758 DO - 10.1158/1535-7163.MCT-15-0758 ID - Ardini2016 ER - TY - JOUR AU - Farago, A. F. AU - Le, L. P. AU - Zheng, Z. PY - 2015 DA - 2015// TI - Durable clinical response to entrectinib in NTRK1-rearranged non-small cell lung cancer JO - J Thorac Oncol VL - 10 UR - https://doi.org/10.1097/01.JTO.0000473485.38553.f0 DO - 10.1097/01.JTO.0000473485.38553.f0 ID - Farago2015 ER - TY - BOOK AU - Demetri, G. D. AU - Paz-Ares, L. AU - Farago, A. F. PY - 2018 DA - 2018// TI - Efficacy and safety of entrectinib in patients with NTRK fusion-positive tumors: pooled analysis of STARTRK-2, STARTRK-1 and ALKA-372-001 PB - ESMO Congress CY - Munich ID - Demetri2018 ER - TY - JOUR AU - Robinson, G. W. AU - Gajjar, A. J. AU - Gauvain, K. M. PY - 2019 DA - 2019// TI - Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors JO - Am Soc Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2019.37.15_suppl.10009 DO - 10.1200/JCO.2019.37.15_suppl.10009 ID - Robinson2019 ER - TY - JOUR AU - Lao, I. W. AU - Sun, M. AU - Zhao, M. PY - 2018 DA - 2018// TI - Lipofibromatosis-like neural tumour: a clinicopathological study of ten additional cases of an emerging novel entity JO - Pathology VL - 50 UR - https://doi.org/10.1016/j.pathol.2018.03.007 DO - 10.1016/j.pathol.2018.03.007 ID - Lao2018 ER - TY - BOOK PY - 2020 DA - 2020// TI - Classification of tumors: soft tissue and bone tumors PB - WHO CY - Geneva ID - ref18 ER - TY - JOUR AU - Bartenstein, D. W. AU - Coe, T. M. AU - Gordon, S. C. PY - 2018 DA - 2018// TI - Lipofibromatosis-like neural tumor: case report of a unique infantile presentation JO - JAAD Case Rep VL - 4 UR - https://doi.org/10.1016/j.jdcr.2017.09.004 DO - 10.1016/j.jdcr.2017.09.004 ID - Bartenstein2018 ER - TY - JOUR AU - Wong, V. AU - Pavlick, D. AU - Brennan, T. PY - 2016 DA - 2016// TI - Evaluation of a congenital infantile fibrosarcoma by comprehensive genomic profiling reveals an LMNA-NTRK1 gene fusion responsive to crizotinib JO - J Natl Cancer Inst VL - 108 UR - https://doi.org/10.1093/jnci/djv307 DO - 10.1093/jnci/djv307 ID - Wong2016 ER - TY - JOUR AU - Chiang, S. AU - Cotzia, P. AU - Hyman, D. M. PY - 2018 DA - 2018// TI - NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma JO - Am J Surg Pathol VL - 42 UR - https://doi.org/10.1097/PAS.0000000000001055 DO - 10.1097/PAS.0000000000001055 ID - Chiang2018 ER - TY - JOUR AU - Penault-Llorca, F. AU - Rudzinski, E. R. AU - Sepulveda, A. R. PY - 2019 DA - 2019// TI - Testing algorithm for identification of patients with TRK fusion cancer JO - J Clin Pathol VL - 72 UR - https://doi.org/10.1136/jclinpath-2018-205679 DO - 10.1136/jclinpath-2018-205679 ID - Penault-Llorca2019 ER - TY - JOUR AU - Marchio, C. AU - Scaltriti, M. AU - Ladanyi, M. PY - 2019 DA - 2019// TI - ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research JO - Ann Oncol VL - 30 UR - https://doi.org/10.1093/annonc/mdz204 DO - 10.1093/annonc/mdz204 ID - Marchio2019 ER - TY - JOUR AU - Lam, S. W. AU - Cleton-Jansen, A. M. AU - Cleven, A. H. G. PY - 2018 DA - 2018// TI - Molecular analysis of gene fusions in bone and soft tissue tumors by anchored multiplex PCR-based targeted next-generation sequencing JO - J Mol Diagn VL - 20 UR - https://doi.org/10.1016/j.jmoldx.2018.05.007 DO - 10.1016/j.jmoldx.2018.05.007 ID - Lam2018 ER -